Novo Ventures portfolio

Novo Ventures has 2 portfolio companies on record at Recent Funding.

Type: Investor.

Portfolio on Recent Funding: 2.

Deals, last 12 months: 0.

Capital in their rounds: $220M.

Latest deal: Amolyt Pharma · Jan 6, 2023.

About this page

Its most recent investment on record is Amolyt Pharma's $140M Series B+ round in January 2023, alongside Mass General Brigham Ventures, Intermediate Capital Group, Pontifax and 6 others. By category, its portfolio leans toward Health and bio (2) and Consumer and social (1). It has co-invested with OrbiMed, Mass General Brigham Ventures and Kurma Partners, most often OrbiMed (2 rounds).

What Novo Ventures invests in

Health and bio · 2 · 100%
Consumer and social · 1 · 50%
Cybersecurity · 1 · 50%

How Novo Ventures invests

Stage	Deals	Capital in rounds
Series B+	2 100%	$220M

Year	Deals	Capital in rounds
2021	1 50%	$80M
2023	1 50%	$140M

Novo Ventures portfolio companies

AAmolyt Pharma$140MSeries B+ · Jan 2023
FF2Gbacker

Company	Round with Novo Ventures	Total raised	Latest raise
AAmolyt Pharma Health and bio	Jan 6, 2023 Series B+ · $140M	$294M	Jan 6, 2023 Series B+
FF2G Health and bio	backer	$100M	Sep 12, 2024 Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Novo Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Novo Ventures, which is a subset of its real portfolio. API: /api/v1/investors/novo-ventures (get a free API key). More: the most active VC firms and new venture capital funds.